Evidence map›Paper›PMID 40672207›Full record

ArticlebioRxiv : the preprint server for biology2025

GAME: Genomic API for Model Evaluation.

Ishika Luthra, Satyam Priyadarshi, Rui Guo, Lukas Mahieu, Niklas Kempynck, Damion Dooley, Dmitry Penzar, Ilya Vorontsov, Yilun Sheng, Xinming Tu and 23 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors.

Ishika LuthraSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
Satyam PriyadarshiSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.
Rui GuoLyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Lukas MahieuVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Niklas KempynckVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Damion DooleyCentre for Infectious Disease Genomics and One Health, Simon Fraser University, Burnaby, BC, Canada.
Dmitry PenzarVavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
Ilya VorontsovVavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
Yilun ShengPaul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA.
Xinming TuPaul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA.
Adam KlieDepartment of Medicine, Division of Genomics and Precision Medicine, University of California San Diego, La Jolla, CA, USA.
Shiron DrusinskyUniversity of California, San Francisco, San Francisco, CA 94143, USA.
Alexander FlorenGladstone Institute of Data Science & Biotechnology, San Francisco, CA, USA.
Ethan ArmandIntegrative Biology Laboratory, Salk Institute for Biological Studies, 10010 N. Torrey Pines Road, La Jolla, CA 92037, USA.
Kaur AlasooInstitute of Computer Science, University of Tartu, Tartu, Estonia.
Georg SeeligPaul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA.
Ryan TewheyThe Jackson Laboratory, Bar Harbor, ME, USA.
Peter KooCold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.
Vikram AgarwalmRNA Center of Excellence, Sanofi, Waltham, MA 02451, USA.
Sager GosaiBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Luca PinelloMolecular Pathology Unit, Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
Michael A WhiteDepartment of Genetics, Washington University in St. Louis, St. Louis, MO, 63110, USA.
Avantika LalBiology Research | AI Development, gRED Computational Sciences, Genentech, South San Francisco, CA, USA.
Julia ZeitlingerStowers Institute for Medical Research, Kansas City, MO 64110, USA.
Katherine S PollardUniversity of California, San Francisco, San Francisco, CA 94143, USA.
Maxwell LibbrechtSchool of Computing Science, Simon Fraser University, Burnaby, British Columbia V51 1S6, Canada.
Hannah CarterDepartment of Medicine, Division of Genomics and Precision Medicine, University of California San Diego, La Jolla, CA, USA.
Sara MostafaviPaul G. Allen School of Computer Science and Engineering, University of Washington, Seattle, WA.
Ivan KulakovskiyVavilov Institute of General Genetics, Russian Academy of Sciences, 119991 Moscow, Russia.
Will HsiaoCentre for Infectious Disease Genomics and One Health, Simon Fraser University, Burnaby, BC, Canada.
Stein AertsVIB Center for AI & Computational Biology, VIB-KU Leuven Center for Brain and Disease Research & KU Leuven Department of Human Genetics, Leuven, Belgium.
Jian ZhouLyda Hill Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carl G de BoerSchool of Biomedical Engineering, University of British Columbia, Vancouver, BC, Canada.

Funding

Sequence models of genome regulatory architecture in 3DDP2GM146336 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI ZHOU, JIAN · 2021 to 2024
$2.5M
DISCOVERY OF DNA DETERMINANTS OF TRANSCRIPTION FACTOR BINDING AND FUNCTION IN PHOR01GM121755 · NIGMS · WASHINGTON UNIVERSITY · PI WHITE, MICHAEL AARON · 2017 to 2021
$1.5M
NIGMS NIH HHS DP2 GM146336NIGMS NIH HHS R01 GM121755
6 · The paper itself

Abstract

The rapid expansion of genomics datasets and the application of machine learning has produced sequence-to-activity genomics models with ever-expanding capabilities. However, benchmarking these models on practical applications has been challenging because individual projects evaluate their models in ad hoc ways, and there is substantial heterogeneity of both model architectures and benchmarking tasks. To address this challenge, we have created GAME, a system for large-scale, community-led standardized model benchmarking on user-defined evaluation tasks. We borrow concepts from the Application Programming Interface (API) paradigm to allow for seamless communication between pre-trained models and benchmarking tasks, ensuring consistent evaluation protocols. Because all models and benchmarks are inherently compatible in this framework, the continual addition of new models and new benchmarks is easy. We also developed a Matcher module powered by a large language model (LLM) to automate ambiguous task alignment between benchmarks and models. Containerization of these modules enhances reproducibility and facilitates the deployment of models and benchmarks across computing platforms. By focusing on predicting underlying biochemical phenomena (e.g. gene expression, open chromatin, DNA binding), we ensure that tasks remain technology-independent. We provide examples of benchmarks and models implementing this framework, and anticipate that the community will contribute their own, leading to an ever-expanding and evolving set of models and evaluation tasks. This resource will accelerate genomics research by illuminating the best models for a given task, motivating novel functional genomic benchmarks, and providing a more nuanced understanding of model abilities.

Identifiers

PMID40672207
PMCPMC12265512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.